| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―May―30 |
The prevalence of long COVID-19 syndrome in hospitalized patients with COVID-19 pneumonia |
|
| 2 |
[GO] |
2024―May―30 |
COVID-19 vaccine-associated lymphadenopathy: a review |
|
| 3 |
[GO] |
2024―May―30 |
Antimicrobial therapies administrated during the Third Plague Pandemic in Europe |
|
| 4 |
[GO] |
2024―Mar―05 |
COVID-19 vaccines-associated Takotsubo cardiomyopathy: A narrative review |
|
| 5 |
[GO] |
2024―Mar―05 |
Investigating the diagnostic and prognostic value of anti-SARS-CoV-2 Spike IgG/IgM ELISA tests in patients infected with coronavirus Delta variant |
|
| 6 |
[GO] |
2023―Dec―06 |
Outcomes of COVID-19 amongst patients with ongoing use of inhaled corticosteroids - a systematic review & meta-analysis |
|
| 7 |
[GO] |
2023―Dec―06 |
Etiological characterization of acute undifferentiated febrile illness in Apartadó and Villeta municipalities, Colombia, during COVID-19 pandemic |
|
| 8 |
[GO] |
2023―Dec―06 |
Splenic infarction: an uncommon yet significant complication in COVID-19 patients - a case series report and literature review |
|
| 9 |
[GO] |
2023―Dec―06 |
Longitudinal evaluation of two different COVID-19 vaccination strategies in individuals with and without previous SARS-CoV-2 infection |
|
| 10 |
[GO] |
2023―Dec―06 |
Synergistic fight against future pandemics: Lessons from previous pandemics |
|
| 11 |
[GO] |
2023―Mar―04 |
COVID-19 and tuberculosis coinfection: outcomes depend on severity of COVID-19 and comorbid conditions |
|
| 12 |
[GO] |
2023―Mar―04 |
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study |
|
| 13 |
[GO] |
2023―Mar―04 |
The future for COVID-19 vaccines: public health assessment and perspectives based on scientific evidence |
|
| 14 |
[GO] |
2023―Mar―04 |
Risk factors and outcomes of fungal superinfections in patients with severe COVID-19: an observational study from Pisa academic hospital |
|
| 15 |
[GO] |
2023―Mar―04 |
Gingival presentation of mucormycosis post infection with COVID-19: series of 3 cases |
|
| 16 |
[GO] |
2023―Mar―04 |
Invasive cryptococcal disease in COVID-19: systematic review of the literature and analysis |
|
| 17 |
[GO] |
2022―Dec―06 |
Prognostic evaluation of Acinetobacter baumannii ventilatorassociated pneumonia in COVID-19 |
|
| 18 |
[GO] |
2022―Dec―06 |
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study |
|
| 19 |
[GO] |
2022―Dec―06 |
Clinical impact of COVID-19 on tuberculosis |
|
| 20 |
[GO] |
2022―Dec―06 |
Corticosteroids use for COVID-19: an overview of systematic reviews |
|
| 21 |
[GO] |
2022―Dec―06 |
Detection of human adenovirus among Iranian pediatric hospitalized patients suspected of COVID-19: epidemiology and comparison of clinical features |
|
| 22 |
[GO] |
2022―Dec―06 |
Efficacy and safety of oral antivirals in individuals aged 80 years or older with mild-to-moderate COVID-19: preliminary report from an Italian Prescriber Center |
|
| 23 |
[GO] |
2022―Dec―06 |
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy |
|
| 24 |
[GO] |
2022―Dec―06 |
The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends |
|
| 25 |
[GO] |
2022―Aug―30 |
Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey |
|
| 26 |
[GO] |
2022―Aug―30 |
Home management of COVID-19 symptomatic patients: a safety study on COVID committed home medical teams |
|
| 27 |
[GO] |
2022―Aug―30 |
Comparison of clinical characteristics and outcome in RT-PCR positive and false-negative RT-PCR for COVID-19: A Retrospective analysis |
|
| 28 |
[GO] |
2022―Aug―30 |
A comparative overview of SARS-CoV-2 and its variants of concern |
|
| 29 |
[GO] |
2022―Aug―30 |
MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management |
|
| 30 |
[GO] |
2022―Aug―30 |
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? |
|
| 31 |
[GO] |
2022―Aug―30 |
The Manchurian pandemic of pneumonic plague (1910-1911) |
|
| 32 |
[GO] |
2022―Jun―08 |
Impact of COVID-19 severity on health-related quality of life among Saudi adult patients |
|
| 33 |
[GO] |
2022―Jun―08 |
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study |
|
| 34 |
[GO] |
2022―Jun―08 |
Healthcare workers, epidemic biological risks - recommendations based on the experience with COVID-19 and Ebolavirus |
|
| 35 |
[GO] |
2022―Jun―08 |
Development of a nomogram to assess the impact of the myocardial injury on the prognosis of COVID-19 patients |
|
| 36 |
[GO] |
2022―Jun―08 |
Cutaneous complications of COVID-19 vaccines |
|
| 37 |
[GO] |
2022―Jun―08 |
Pathological involvement of placenta in COVID-19: a systematic review |
|
| 38 |
[GO] |
2022―Mar―14 |
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 |
|
| 39 |
[GO] |
2022―Mar―14 |
Differential mortality with COVID-19 and invasive mechanical ventilation between high-income and low- and middle-income countries: a systematic review, meta-analysis, and meta-regression |
|
| 40 |
[GO] |
2022―Mar―14 |
Comparison of COVID-19 characteristics in Egyptian patients according to their Toll-Like Receptor-4 (Asp299Gly) polymorphism |
|
| 41 |
[GO] |
2022―Mar―14 |
The impact of COVID-19 on communicable and non-communicable diseases in Africa: a narrative review |
|
| 42 |
[GO] |
2022―Mar―14 |
The serious threat of late presenters HIV-infected patients in the context of the COVID-19 pandemic |
|
| 43 |
[GO] |
2022―Mar―14 |
Epidemiology of respiratory virus before and during COVID-19 pandemic |
|
| 44 |
[GO] |
2022―Mar―14 |
Evolution of prescribing practices and outcomes in the COVID-19 pandemic in metropolitan areas |
|
| 45 |
[GO] |
2022―Mar―14 |
Long Covid-19 syndrome as a fourth phase of Sars-CoV2 infection |
|
| 46 |
[GO] |
2022―Mar―14 |
A review of adverse effects of COVID-19 vaccines |
|
| 47 |
[GO] |
2022―Mar―14 |
COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications |
|
| 48 |
[GO] |
2022―Mar―14 |
Liver involvement and mortality in COVID-19: A retrospective analysis from the CORACLE study group |
|
| 49 |
[GO] |
2022―Mar―14 |
Can food matrices be considered as a potential carrier for COVID-19? |
|
| 50 |
[GO] |
2021―Dec―11 |
Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 era |
|
| 51 |
[GO] |
2021―Dec―11 |
Gastrointestinal manifestations in American minority population with COVID-19 |
|
| 52 |
[GO] |
2021―Dec―11 |
Neutrophil-to-lymphocyte ratio and mean platelet volume in the diagnosis of bacterial infections in COVID-19 patients. A preliminary analysis from Ecuador |
|
| 53 |
[GO] |
2021―Dec―11 |
Global implication of booster doses of COVID-19 vaccine |
|
| 54 |
[GO] |
2021―Dec―11 |
Cranial neuropathy in COVID-19: a case series and review of literature |
|
| 55 |
[GO] |
2021―Dec―11 |
Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review |
|
| 56 |
[GO] |
2021―Dec―11 |
Mucormycosis in COVID-19: A systematic review of literature |
|
| 57 |
[GO] |
2021―Dec―11 |
Pneumocystis jirovecii pneumonia in breast cancer mimicking SARS-CoV-2 pneumonia during pandemic |
|
| 58 |
[GO] |
2021―Sep―17 |
Clinical profile, management and outcome of patients with leptospirosis during the times of COVID-19 pandemic: A prospective study from a tertiary care centre in South India |
|
| 59 |
[GO] |
2021―Sep―17 |
Association between RT-PCR Ct values and COVID-19 new daily cases: a multicenter cross-sectional study |
|
| 60 |
[GO] |
2021―Sep―17 |
COVID-19 infection after mRNA 1273 vaccine: review of the most frequently asked questions |
|
| 61 |
[GO] |
2021―Sep―17 |
SARS-CoV-2 variants of concern: implications on the second wave of COVID-19 in India |
|
| 62 |
[GO] |
2021―Sep―17 |
Sex differences in COVID-19 fatality rate and risk of death: An analysis in 73 countries, 2020-2021 |
|
| 63 |
[GO] |
2021―Sep―17 |
A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy |
|
| 64 |
[GO] |
2021―Sep―17 |
Review of COVID-19 viral vector-based vaccines and COVID-19 variants |
|
| 65 |
[GO] |
2021―Sep―17 |
Current status of therapeutic alternatives for COVID-19: A narrative review |
|
| 66 |
[GO] |
2021―Sep―17 |
Myocardial injuries among patients with COVID-19: a systematic review |
|
| 67 |
[GO] |
2021―Sep―17 |
Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19? |
|
| 68 |
[GO] |
2021―Sep―17 |
CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia |
|
| 69 |
[GO] |
2021―Sep―17 |
Epidemiological and clinical features of Spanish flu in the city of Ferrara and in Italy. Containment rules and health measures adopted in the past to fight the pandemic |
|
